Governor Paterson Busy Protecting Citizens from Harmful Doctors, Drugs, Toys and Sexual Predators – Part 2

Part 2 of this topic discusses new legislation regarding dangerous drugsdefective toys and sexual predators using the internet to prowl and prey. The information herein is set forth in press releases issued by the governor’s office. Proposed legislation designed to protect patients from medical malpractice was discussed in Part 1 of this blog. Governor David A. Paterson has … Read the rest

Governor Paterson Busy Protecting Citizens from Harmful Doctors, Drugs, Toys and Sexual Predators – Part 1

Last week was a busy week for New York’s Governor David A. Paterson on issues often written about in this blog – medical malpracticedangerous drugsdefective toys and sexual predators using the internet. Some bills were signed, others introduced. The most ambitious of these was on the medical malpractice front, Governor Paterson proposed legislation that offers … Read the rest

Encouraging News? Congress Prepares to Undo Anticipated Supreme Court Decision Precluding Lawsuits Over Dangerous Drugs

In the event that the Supreme Court applies the federal doctrine of preemption to permit the pharmaceutical industry to avoid accountability for the harm dangerous drugs cause, the only remedy would be for Congress to pass a law expressly stating that preemption does not preclude state court lawsuits for compensation.

And that, hopefully, is the goal of the process engaged … Read the rest

Exposure of Vioxx “Ghostwriting” Another Example of How Litigation Can Benefit Society (and Why Big Business/Pharma Fears It)

Product liability litigation involving rofecoxib (Vioxx) has led to the disclosure of materials that has provided direct evidence of something that has long been suspected but well-hidden by industry; the manipulation of pharmaceutical studies by for-profit manufacturers of pharmaceuticals and medical devices of study results, using authors, editors, and reviewers to misrepresent research data and manipulate clinical research … Read the rest

FDA Triples The Number Of Deaths It Attributes To Side Effects Of Heparin

The Food and Drug Administration yesterday raised from 19 to 62 its estimate of the number of people who may have died after suffering allergic reactions or hypotension to contaminated Chinese-produced batches of the blood thinner heparin.

Last month the FDA determined that Baxter Healthcare Corporation’s drug was contaminated with an unnatural chemical during production at a plant in … Read the rest

Taking Mirapex or Requip for Restless Leg Syndrome? Beware of “Disease Mongering”

“Disease mongering” is a term coined by some drug-marketing critics to describe what they view as an effort by pharmaceutical companies to enlarge the market for a drug by convincing people that they are suffering from something that can be medically treated and encouraging them to ask their doctor to prescribe the drug in order to enlarge the market for … Read the rest

17 More Deaths and More Recalls Associated with Heparin

The U.S. Food and Drug Administration said the number of deaths possibly associated with the drug heparin, made from pig intestines, had risen to 21 from 4. The reported number of those suffering adverse reactions increased from approximately 350 to 455. Both increases have been reported within just a 2 week time period. But the F.D.A. cautioned that many … Read the rest

Suspension of Heparin Sales More than a Matter of Products Liability; Described as “a National Security Issue.”

Since Baxter International announced recently that it was suspending sales of its multidose vials of heparin after four patients died and 350 suffered complications including allergic reactions, many of them serious and potentially life-threatening, significant concerns have arisen as to the effectiveness of the U.S. Food and Drug Administration’s oversight of imported drugs. Baxter bought the active ingredient for heparin, … Read the rest

FDA Issues Public Health Advisory on Chantix, Which May Become the Subject of Product Liability Suits

The U.S. Food and Drug Administration (FDA) on February 1, 2008, issued a Public Health Advisory to alert health care providers, patients, and caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to help patients stop smoking.

Serious neuropsychiatric symptoms have occurred in patients taking Chantix. These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, … Read the rest

Drug Makers Release Test Results That Shows That Their Cholesterol Drug Zetia Has No Benefits

Merck and Schering- Plough, the makers of the popular cholesterol drug, Zetia, announced that Zetia and Vytorin, a pill containing Zetia and Zocor, had failed to benefit patients of a two-year trial which was completed in April of 2006. Merck and Schering-Plough’s press release stated that Zetia not only failed to slow down the accumulation of fatty plaque in … Read the rest